346 related articles for article (PubMed ID: 34978050)
1. Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis.
Ionita C; Marcelli D; Nita C; Anton C; Berca S; Vacar S; Schiller O; Gheorghiu C; Barth C
J Nephrol; 2022 Jan; 35(1):143-151. PubMed ID: 34978050
[TBL] [Abstract][Full Text] [Related]
2. Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.
Kohmer N; Rabenau HF; Ciesek S; Krämer BK; Göttmann U; Keller C; Rose D; Blume C; Thomas M; Lammert A; Lammert A
Nephrol Dial Transplant; 2022 May; 37(6):1132-1139. PubMed ID: 35099023
[TBL] [Abstract][Full Text] [Related]
3. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.
Broseta JJ; Rodríguez-Espinosa D; Rodríguez N; Mosquera MDM; Marcos MÁ; Egri N; Pascal M; Soruco E; Bedini JL; Bayés B; Maduell F
Am J Kidney Dis; 2021 Oct; 78(4):571-581. PubMed ID: 34174364
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
5. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos C; Lucas C; Macario F; Haase M
J Nephrol; 2021 Aug; 34(4):975-983. PubMed ID: 34050904
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine.
Carta M; Marinello I; Cappelletti A; Rodolfi A; Cerrito E; Bernasconi C; Gottardo M; Dal Lago F; Rizzetto D; Barzon E; Giavarina D
Am J Clin Pathol; 2022 Feb; 157(2):212-218. PubMed ID: 34463321
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients.
Aoun M; Kahwaji RM; Sleilaty G; Boueri C; Hawi J; Khalil CB; Hage V
Adv Clin Exp Med; 2022 Aug; 31(8):855-861. PubMed ID: 35438849
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune response after different SARS-CoV-2 vaccination regimens.
Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
[TBL] [Abstract][Full Text] [Related]
11. Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.
Sibbel S; McKeon K; Luo J; Wendt K; Walker AG; Kelley T; Lazar R; Zywno ML; Connaire JJ; Tentori F; Young A; Brunelli SM
J Am Soc Nephrol; 2022 Jan; 33(1):49-57. PubMed ID: 34789546
[TBL] [Abstract][Full Text] [Related]
12. Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
Van Praet J; Reynders M; De Bacquer D; Viaene L; Schoutteten MK; Caluwé R; Doubel P; Heylen L; De Bel AV; Van Vlem B; Steensels D; De Vriese AS
J Am Soc Nephrol; 2021 Dec; 32(12):3208-3220. PubMed ID: 34588184
[TBL] [Abstract][Full Text] [Related]
13. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Speich B; Chammartin F; Abela IA; Amico P; Stoeckle MP; Eichenberger AL; Hasse B; Braun DL; Schuurmans MM; Müller TF; Tamm M; Audigé A; Mueller NJ; Rauch A; Günthard HF; Koller MT; Trkola A; Briel M; Kusejko K; Bucher HC;
Clin Infect Dis; 2022 Aug; 75(1):e585-e593. PubMed ID: 35234868
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patients.
Di Meo A; Ma L; Yau K; Abe KT; Colwill K; Gingras AC; Kozak R; Hladunewich MA; Yip PM
Clin Biochem; 2023 Nov; 121-122():110681. PubMed ID: 37913837
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
Olariu TR; Ursoniu S; Marincu I; Lupu MA
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
[No Abstract] [Full Text] [Related]
16. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response.
Di Meo A; Miller JJ; Fabros A; Brinc D; Hall V; Pinzon N; Ierullo M; Ku T; Ferreira VH; Kumar D; Pasic MD; Kulasingam V
J Appl Lab Med; 2022 Jan; 7(1):57-65. PubMed ID: 34342347
[TBL] [Abstract][Full Text] [Related]
17. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.
Grupper A; Sharon N; Finn T; Cohen R; Israel M; Agbaria A; Rechavi Y; Schwartz IF; Schwartz D; Lellouch Y; Shashar M
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1037-1042. PubMed ID: 33824157
[TBL] [Abstract][Full Text] [Related]
18. Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
Milazzo L; Pezzati L; Oreni L; Kullmann C; Lai A; Gabrieli A; Bestetti G; Beschi C; Conti F; Ottomano C; Gervasoni C; Meroni L; Galli M; Antinori S; Ridolfo AL
Hum Vaccin Immunother; 2021 Dec; 17(12):4747-4754. PubMed ID: 35086438
[TBL] [Abstract][Full Text] [Related]
19. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
[TBL] [Abstract][Full Text] [Related]
20. Humoral response to SARS-CoV-2 vaccination promises to improve the catastrophic prognosis of hemodialysis patients as a result of COVID-19: the COViNEPH Project.
Tylicki L; Biedunkiewicz B; Dąbrowska M; Ślizień W; Tylicki P; Polewska K; Rosenberg I; Rodak S; Dębska-Ślizień A
Pol Arch Intern Med; 2021 Sep; 131(9):797-801. PubMed ID: 34351091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
